Track market-moving stories before they get noisy

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against First Solar, Inc. (NASDAQ: FSLR) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired First Solar securities between February 26, 2025 and February 24, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/FSLR.

First Solar Case Details

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges that:

 (1)Defendants had overstated First Solar’s capacity to manage the impact of U.S. tariff policy on the Company’s business (2)Defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar’s projected performance in the 2026 fiscal year; (3)as a result, Defendants’ public statements were materially false and misleading at all relevant times.
What's Next for First Solar Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/FSLR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in First Solar you have until August 24, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to First Solar Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for First Solar Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Palantir (NASDAQ:PLTR | PLTR Price Prediction) has been down 29.92% year to date while the S&P 500 has gained 9.60%. But the one reason Palantir can beat the market from here is the same reason it has beaten it over five years: a Rule of 40 score of 145%, matched only by NVIDIA (NASDAQ:NVDA), Micron (NASDAQ:MU), and SK hynix.

Our 24/7 Wall St. price target for Palantir is $162.35, implying 30.33% upside from $124.57. Recommendation: Buy. Confidence: high, at 90%.

24/7 Wall St. Price Target Summary Metric Value Current Price $124.57 24/7 Wall St. Price Target $162.35 Upside 30.33% Recommendation BUY Confidence Level 90% Why Palantir Sold Off Despite Blowout Numbers Palantir sits 12% below its 52-week high of $207.52 and roughly 17% above its 52-week low of $106.37. Shares are down 6.87% in the past week.

Yet fundamentals keep improving. In Q1 FY2026, filed May 4, 2026, adjusted EPS of $0.33 beat the $0.2795 consensus by 18.07%, and revenue of $1.63 billion grew 84.71% YoY, extending the streak to eight straight EPS beats.

U.S. commercial revenue jumped 133% YoY to $595 million, and management raised FY2026 revenue guidance to $7.650 to $7.662 billion (71% growth). Over five years, PLTR is up 471.16%.

The Case for $200+ Our bull scenario projects PLTR reaching $203.55 in 12 months, a 63.4% total return. U.S. commercial acceleration anchors this path: remaining deal value ended Q1 at $4.92 billion, up 112% YoY, and TCV closed was $2.41 billion (+61% YoY).

Free cash flow more than tripled to $925 million, with FY2026 adjusted FCF guided to $4.2 to $4.4 billion. The Street consensus target of $183.12 sits between our base and bull cases.

The Risks Worth Watching PLTR trades at a trailing P/E of 150x and forward P/E of 91x, versus an implied model P/E of 131x. Our bear scenario lands at $142.36 (+14.29%), but broader multiple compression could retest the 52-week low.

SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now.

Stock-based compensation of $201.6 million in Q1 and government contract termination-for-convenience clauses are legitimate concerns. GAAP operating income of $754 million (46% margin) demonstrates genuine GAAP profitability, a mark most software peers cannot claim even after backing out SBC.

How Palantir Compares to Snowflake and CrowdStrike Snowflake (NYSE:SNOW) is the closest data-platform peer, but the growth gap is wide: SNOW grew Q1 FY27 revenue 33.5% YoY and remains GAAP-unprofitable with an operating margin of -30.6%.

Palantir grew 84.71% at a 46% operating margin. Our $162.35 target looks conservative relative to what investors pay for slower, unprofitable data infrastructure.

CrowdStrike (NASDAQ:CRWD) offers a better valuation contrast. CRWD grew Q1 FY27 revenue 25.6% and carries a $192 billion market cap. Palantir’s $298.6 billion market cap is a premium, but with more than triple the growth rate, the multiple is defensible.

Hold Through the Volatility, Buy on Dips Verdict: Buy, with high (90%) confidence in the 24/7 Wall St. price target of $162.35. The Rule of 40 at 145% combined with FY2026 guidance raised twice already is the tipping factor.

The setup rewards investors who can tolerate a beta of 1.56 across a 12-month horizon. Investors unable to absorb another 30% drawdown may find the risk/reward less compelling. Growth this durable rarely stays this cheap for long.

Palantir Price Prediction 2026-2030 Year 24/7 Wall St. Price Target 2026 $162 2027 $189 2028 $217 2029 $243 2030 $266 These projections assume Palantir executes on U.S. commercial expansion and defends operating margins near 40%. Significant upside or downside could result from major government contract shifts or accelerated enterprise AIP adoption.

Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.

From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus. 

Contact [email protected] for any questions or corrections.

The market expects Bristol Myers Squibb (BMY - Free Report) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report, which is expected to be released on July 30, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis biopharmaceutical company is expected to post quarterly earnings of $1.59 per share in its upcoming report, which represents a year-over-year change of +8.9%.

Revenues are expected to be $11.67 billion, down 4.9% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.12% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Bristol Myers?For Bristol Myers, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.51%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Bristol Myers will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Bristol Myers would post earnings of $1.44 per share when it actually produced earnings of $1.58, delivering a surprise of +9.72%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Bristol Myers appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAmong the stocks in the Zacks Medical - Biomedical and Genetics industry, uniQure (QURE - Free Report) , is soon expected to post loss of $0.89 per share for the quarter ended June 2026. This estimate indicates a year-over-year change of -29%. This quarter's revenue is expected to be $7.05 million, up 34% from the year-ago quarter.

The consensus EPS estimate for uniQure has been revised 0.5% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +12.03%.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that uniQure will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Netflix (NASDAQ:NFLX | NFLX Price Prediction) and Roku (NASDAQ:ROKU) just delivered post-earnings snapshots that could not look more different. Netflix posted its Q2 report on July 16, leaning on content, ads, and the largest buyback quarter in its history. Roku’s Q1, filed April 30, showed a platform business finally translating scale into consistent profits.

Big Content Wins Meet Ad Tech Roars Netflix delivered EPS of $0.80 on revenue of $12.559 billion, growing 13.37% YoY. Operating margin held at 33.4%, doing the heavy lifting. Titles like Apex (131M views) and Swapped (137M views) kept engagement steady while price hikes in the US, Mexico, and Spain landed without much pushback.

Roku’s quarter was louder in percentage terms. Platform revenue climbed 28% YoY to $1.13 billion, with Advertising up 27% and Subscriptions up 30%. CEO Anthony Wood told investors, “We delivered an outstanding first quarter.” Devices slipped 16%, a reminder that the hardware business still runs at a loss.

One Owns the Screen, the Other Owns the Feed Lens Netflix Roku Core Bet Content plus live sports Programmatic ads and SMBs Growth Lever Ad tier doubling to ~$3B Platform toward ~$5B Capital Return $27.1B buyback remaining $400M program Key Risk $1B debt maturing 2026 Memory chip supply squeeze Netflix is chasing time on screen with an expanded NFL package including Thanksgiving Eve and Christmas Gameday, plus creator deals with Ms. Rachel and Mark Rober. Roku is chasing the dollars flowing through its pipes, integrating with DV360, Amazon DSP, and The Trade Desk. Advertiser count on Roku Ads Manager more than doubled YoY. Two very different revenue engines.

The Next Test Sits in Very Different Places For Netflix, I want to see ad revenue actually reach that $3.0 billion target while free cash flow rebounds from Q2’s $1.525 billion figure. Reddit chatter has soured alongside a 26.91% YTD drop, with a thread called “Netflix’s Growth Engine Is Stalling” gaining traction. For Roku, the tell will be Q2 earnings on July 30. Polymarket traders put the odds of a beat at 87%, though I take small-volume markets with a grain of salt.

Why I’d Split the Ticket Personally, I lean Netflix for stability. The sell-off dragged shares to $68.53, and a P/E near 21 feels reasonable for a business guiding to roughly $12.5 billion in free cash flow. For investors researching more torque, Roku offers a different profile. Platform economics are compounding, and reaching $1 billion of Free Cash Flow by 2028 would reprice the shares meaningfully. I would hesitate on Roku if memory chip costs pressure device margins harder than expected. Together, the pair covers the defensive and growth ends of streaming.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Netflix didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

Although most people only interact with artificial intelligence (AI) through generative AI tools like ChatGPT, there are tons of working parts behind the scenes that make it happen.

In the earlier stages of the current AI mania we're experiencing, attention was on the companies making graphics processing units (GPUs) and AI accelerators. Then, attention went to companies building out data centers and other infrastructure. Now, it seems the focus has gotten a bit more niche, with memory chip makers among the hottest (and most volatile) stocks on the market.

Demand for memory hardware has shot up in the past couple of years, far outpacing supply. And while a few key companies are working to address it, it's not an issue that'll be fixed overnight.

Image source: Getty Images.

At the right place at the right time SK Hynix (SKHY +4.89%), Micron Technology (MU +3.28%), and Sandisk (SNDK +4.89%) are three of the key memory and storage hardware companies in the world, and they've found themselves in the right place at the right time.

As AI continues to scale, it requires much more memory and storage. Data centers are filled with countless pieces of this hardware, and as big tech companies spend trillions in the near future building them and other AI infrastructure, their need for it has only grown.

Of course, this supply shortage isn't ideal for data center operators. But for the memory companies making these products, the law of supply and demand has them bringing in cash like never before as they raise prices and flex their pricing power. Here's how much each company increased its revenue and net income in their latest quarters:

CompanyRevenue GrowthNet Income GrowthSK Hynix198%398%Micron346%1,223%SanDisk233%8,646%* Table by author. Growth is year over year. *Sandisk went from a $43 million loss to $3.675 billion in non-GAAP net income.

They're surely enjoying the cash, but they're also focused on addressing the supply problem. The short-term boost is cool; sustainability is much better. And with growing capital expenditure plans, it's clear they understand that as well.

Today's Change

(

4.89

%) $

78.20

Current Price

$

1,677.47

Each company has something good working in its favor SK Hynix only began trading on a U.S. stock exchange (the Nasdaq) on July 10, so it's closer to an initial public offering (IPO) stock, although it has been trading on the Korean Exchange since December 1996. The company is the market leader in high-bandwidth memory (HBM), which is working out in its favor, including inking a multiyear technology partnership with Nvidia that Nvidia says aligns with its "AI infrastructure roadmap."

Micron, up 174% this year (as of market close on July 20), is much smaller than SK Hynix in terms of market share, but it has been posting strong financial results. Its $18.3 billion in free cash flow in its most recent quarter (ended May 28) was up 165% year over year, and its gross margins increased by 10 percentage points from the previous quarter to 84.9%.

Today's Change

(

3.28

%) $

31.47

Current Price

$

990.95

After spinning off from Western Digital in February 2025 and becoming a stand-alone, pure-play storage company, SanDisk has been one of the best-performing stocks in all of the market. Its stock is up nearly 3,700% since the spin-off and 405% this year.

It operates on a smaller scale than the other two, but its financial results have been just as impressive. In the past year, its free cash flow has increased by 1,243% to $2.96 billion, and its non-GAAP gross margins went from 22.7% to 78.4%.

Today's Change

(

4.89

%) $

78.20

Current Price

$

1,677.47

Is now the time to invest in memory stocks? The memory hardware industry is booming right now, but it's also one of the more cyclical tech industries around. Once supply catches up to demand -- and it will catch up -- and companies can no longer command premium prices, the financial growth we see now will likely slow down, and you'll see some investors jumping ship.

There's a lot of speculation right now in memory stocks, which is a large part of why they've been so volatile. If you're more on the risk-averse side, I would avoid memory stocks right now because of the volatility. If you can stomach the volatility, then SK Hynix and Micron look much better priced than SanDisk from a value standpoint and are "safer" choices.

However, a better route for most people would be investing in an exchange-traded fund (ETF) that holds the companies. The Roundhill Memory ETF (DRAM +1.51%) is a good example, but it's much more of a supplemental piece than a portfolio staple.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?

Let's take a look at what these Wall Street heavyweights have to say about Intuitive Surgical, Inc. (ISRG - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Intuitive Surgical currently has an average brokerage recommendation (ABR) of 1.69, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 32 brokerage firms. An ABR of 1.69 approximates between Strong Buy and Buy.

Of the 32 recommendations that derive the current ABR, 21 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 65.6% and 6.3% of all recommendations.

Brokerage Recommendation Trends for ISRG

Check price target & stock forecast for Intuitive Surgical here>>>

While the ABR calls for buying Intuitive Surgical, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Is ISRG a Good Investment?In terms of earnings estimate revisions for Intuitive Surgical, the Zacks Consensus Estimate for the current year has increased 3.1% over the past month to $10.7.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Intuitive Surgical. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Intuitive Surgical may serve as a useful guide for investors.

Investors interested in Consumer Discretionary stocks should always be looking to find the best-performing companies in the group. Is AMC Entertainment (AMC - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Consumer Discretionary peers, we might be able to answer that question.

AMC Entertainment is one of 259 companies in the Consumer Discretionary group. The Consumer Discretionary group currently sits at #9 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. AMC Entertainment is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past three months, the Zacks Consensus Estimate for AMC's full-year earnings has moved 4.1% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the most recent data, AMC has returned 44.2% so far this year. Meanwhile, stocks in the Consumer Discretionary group have lost about 11.5% on average. As we can see, AMC Entertainment is performing better than its sector in the calendar year.

One other Consumer Discretionary stock that has outperformed the sector so far this year is Bassett Furniture (BSET - Free Report) . The stock is up 22.9% year-to-date.

The consensus estimate for Bassett Furniture's current year EPS has increased 7.9% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, AMC Entertainment belongs to the Leisure and Recreation Services industry, which includes 28 individual stocks and currently sits at #83 in the Zacks Industry Rank. Stocks in this group have lost about 8% so far this year, so AMC is performing better this group in terms of year-to-date returns.

In contrast, Bassett Furniture falls under the Furniture industry. Currently, this industry has 7 stocks and is ranked #30. Since the beginning of the year, the industry has moved +2.3%.

Going forward, investors interested in Consumer Discretionary stocks should continue to pay close attention to AMC Entertainment and Bassett Furniture as they could maintain their solid performance.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

MercadoLibre (NASDAQ:MELI | MELI Price Prediction) trades at $1,799.21 against a Wall Street consensus target of $2,214.88, an implied gap of roughly 23%. Scotiabank’s Hector Maya carries a Sector Outperform rating and $2,800 Street-high target on the stock, which implies roughly 55% upside, well above the 40% threshold that flags an outlier call.

MercadoLibre runs Latin America’s dominant e-commerce and fintech ecosystem, pairing the Mercado Libre marketplace with Mercado Pago payments, Mercado Envios logistics, advertising, and a fast-scaling credit card book. The stock sits on a bruised Q1 2026 print that has the market debating temporary land grab versus structural damage.

Margins Collapsed and the Market Reacted Violently Revenue hit $8.85 billion, up 49% year-over-year and beating the $8.32 billion consensus, but operating income fell 20% to $611 million, operating margin compressed roughly 600 basis points to 6.9%, and adjusted free cash flow flipped negative at -$56 million. Shares dropped 15.8% in the first week after the print.

Provisions for doubtful accounts more than doubled to $1.244 billion, and management disclosed it had extended average Brazilian loan terms from 5 months to 8 months while pushing into riskier borrower segments. Multiple law firms opened securities investigations, and the CFO signaled the aggressive investment posture would continue through 2026 with no near-term margin relief expected.

Why 20 of 24 Analysts Still Rate It Buy The bull case, most aggressively voiced by Maya, frames this as a deliberate margin reset that will reverse once the current investment cycle matures. MercadoLibre is spending near-term operating income to lower free-shipping thresholds, scale first-party retail, and issue credit cards at a pace that grew the portfolio 104% year-over-year to $6.6 billion. Maya argues that at $2,800 the stock trades at roughly 28x NTM EV/FCF, which underprices a company compounding revenue at 20% plus in a region where e-commerce penetration is still mid-teens.

Brazil revenue grew 55% year-over-year, Mexico 62%, advertising revenue 73%, and fintech assets under management 77% to nearly $20 billion. Coverage sits at 20 Buy, 4 Hold, 0 Sell, with Jefferies among recent upgraders and Daiwa the notable trim. Bulls want operating margin re-expansion visible by early 2027 as newer card cohorts season and shipping subsidies stop growing as a share of revenue.

The Peer Group Did Not Fall Together Sea (NYSE:SE) is off 17.79% year to date on the same reinvestment story inside its Monee fintech unit. At $104.88 against a $142.26 analyst target, upside runs about 36% behind 27 Buys and 2 Holds.

Nu Holdings (NYSE:NU), Mercado Pago’s most direct LatAm rival, has slipped 13.32% year to date after its own Q1 credit-provision spike. At $14.51 versus a $17.94 target, upside is roughly 24% with 19 Buys, 2 Holds, and 1 Sell.

The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.

Amazon (NASDAQ:AMZN) is the exception, up 6.08% year to date on AWS strength. At $244.85 against a $312.87 target, upside is about 28% behind 62 Buy ratings and no Sells.

Across the four names, Scotiabank’s $2,800 MELI target remains the largest single upside call.

Where the Numbers Land Against the S&P 500 MELI is down 10.68% year to date and 24.55% over the past twelve months. The S&P 500 has climbed 9.6% year to date and 18.85% over the same year, so the stock trails the index by more than 20 percentage points YTD.

Consensus target of $2,214.88 implies about 23% upside; Maya’s $2,800 implies close to 55%. Coverage runs 24 analysts deep, institutional ownership sits at 87.62%, and the trailing P/E is roughly 48, leaving limited room for further margin misses.

My Take: Cautiously Constructive at Current Levels The bull path holds if operating margin bottoms within two quarters and Brazil credit provisions stabilize as the extended-duration loan book seasons. In that path, revenue keeps compounding above 40% and the multiple re-rates. Maya’s $2,800 simply requires the current investment cycle to prove out on schedule.

The bear path plays out if the loan-duration extension turns out to be underwriting drift to hit growth targets. Rising provisions, 8-month terms, and a softer Brazilian consumer would trap the business in a lower-margin profile, and at 48x earnings there is no cushion for that outcome.

My lean is cautiously constructive. The reinvestment metrics are landing, but I’d anchor closer to the consensus $2,214 target than to $2,800 until the next quarter confirms the credit book is behaving.

If You'd Bought Amazon When the Motley Fool Said To…In September 2002, Stock Advisor told subscribers to buy Amazon. In December 2004, Netflix. In April 2005, Nvidia. The newsletter still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Here's how to get this month's picks:

- Join Stock Advisor for one year, with a 30-day money-back guarantee

- Get this month's two new picks — plus the Top 10 Rankings and the full historical pick list

- Read the analysis, decide for yourself, and trade through your own brokerage

Five years from now, you'll probably wish you'd bought this month's picks. Don't miss them.

Contact [email protected] for any questions or corrections.

Brent crude oil surged Thursday to $100 a barrel for the first time since May following reported Houthi attacks on vessels in the Red Sea – fueling concerns that global energy supplies could get even more badly disrupted.

Brent crude oil prices had soared 7.1% to $100.74 a barrel as of about 10:50 a.m. ET, while West Texas Intermediate crude jumped 5.3% to $91.40 – setting the benchmarks up for huge monthly gains of roughly 40% and 30%, respectively.

Oil prices were already climbing this week as traders grew concerned over a breakdown in peace talks between the US and Iran and renewed hostilities in the Strait of Hormuz, a vital maritime route for 20% of the world’s oil supplies that has been largely blockaded for months.

A satellite image of the Bab el-Mandeb Strait, a vital maritime route to the Red Sea. via REUTERS Reports of fresh strikes in the Red Sea raised new fears that a second critical shipping route through the Bab el-Mandeb Strait, which carries about 7% of global oil supplies, could also be compromised – multiplying what is already the world’s worst-ever supply disruption.

The United Kingdom Maritime Trade Operations posted on social media Thursday that a tanker was hit around 70 nautical miles off the coast of Saudi Arabia, sparking a fire onboard that the crew was fighting.

There were no reported casualties. 

Yemen’s Houthis, an Iranian-backed militant group, claimed the attack, saying they fired at two vessels in the Red Sea for allegedly violating their maritime blockade against Saudi Arabia.

Joe Adamski, managing director of ProcureAbility, a supply chain consultancy, told The Post it is “difficult to say for sure” where oil prices are headed since it is “unclear if the Houthis can maintain any kind of a blockade or effectively target shipping and/or Saudi export infrastructure.”

“If the shooting continues, pricing will stay above $100, probably into the $110 to $120 range,” Adamski said. “If that stabilizes or appears manageable, I’d expect to see mid-$80s.”

Jeff Krimmel, founder of Krimmel Strategy, warned that oil prices could keep rising as long as fighting continues in the Red Sea and the Persian Gulf, and both sides continue to trade threats.

“When the direction of travel is toward more conflict, as it is right now, there is no safe ceiling above oil prices,” he told The Post.

“For oil prices to drop, we would need indications of real ongoing diplomacy between the US and Iran,” though a “robust agreement” is not necessary, Krimmel added.

“The market has been clear it will give both sides the benefit of the doubt. We simply need to see a meaningful embrace of diplomacy for oil prices to drop.”

A tanker sailing in waters north of the Bab el-Mandeb Strait. AP The Houthi attacks have not yet been independently confirmed.

President Trump on Thursday vowed to hold Iran responsible for any attacks by the Houthis – saying he was “very disappointed with” the rebels who “have, until now, acted very professionally and smart” during the war with Tehran, which began Feb. 28.

“Please let this TRUTH serve to represent that if they do this again, the U.S. will hold Iran responsible, in that the Houthis are a Surrogate and/or Proxy of Iran, and major military punishment will be inflicted upon Iran and, of course, the Houthis, themselves,” the president wrote in a Truth Social post.

Secretary of State Marco Rubio told reporters in the Philippines on Thursday that the Houthis were making a mistake getting involved in the Middle East conflict, saying they had been “smart” to largely stay out of the war with Iran.

He claimed that one of the vessels struck by the Houthis had actually been “flagged Chinese,” so the militant organization has risked angering another major world power.

The reported Red Sea attacks came just hours after Trump threatened to destroy an Iranian bridge or power plant each time Iran fires at a ship in the Strait of Hormuz, further escalating tensions.

Tehran responded that it would retaliate against US-affiliated infrastructure and energy assets throughout the region if Washington carries out such strikes.

Traders have grown more concerned about a lasting energy crisis since Trump earlier this month announced a ceasefire deal with Iran was “over,” saying he no longer wanted to deal with “sick people.”

On Wednesday, Rubio said Iran was not being “serious” about reaching a peace agreement.

San Diego, California--(Newsfile Corp. - July 23, 2026) - Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Regeneron Therapeutics, Inc. (NASDAQ: REGN) from August 1, 2025 to May 15, 2026. Regeneron is a pharmaceutical company that discovers, invents, develops, manufactures, tests, and commercializes medicines to treat various disorders worldwide.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is the class period? August 1, 2025 – May 15, 2026

What are the allegations? Robbins LLP is Investigating Allegations that Regeneron Therapeutics, Inc. (REGN) Misled Investors Regarding the Viability of its Phase III Fianlimab-Libtayo Study

According to the complaint, during the relevant period, Regeneron was investigating Fianlimab, a human monoclonal antibody targeting the LAG-3 immune checkpoint receptor on T-cells. Fianlimab was pertinently being tested in combination with Libtayo in a phase 3 study to determine whether the drug combination could serve as a first-line treatment for advanced melanoma (the "Phase III Fianlimab-Libtayo Study"). The study had commenced enrollment in mid-2022.

Plaintiff alleges that defendants provided overwhelmingly positive statements to investors while, at the same time, concealing the true state of Regeneron's Phase III Fianlimab Libtayo Study; notably, that (i) its preliminary statistical assumptions were fundamentally flawed; (ii) the active treatment arm was failing to achieve meaningful clinical differentiation over standard therapies; and (iii) the trial would ultimately fail to reach statistical significance on its primary endpoint even without overperformance of the control arm.

Plaintiff alleges that April 29, 2026, during Regeneron's first quarter earnings call, defendants disclosed the Phase III Fianlimab-Libtayo Study had been altered, expanding the number of patients in the study eligible for "analysis of progression-free survival." On this news, the price of Regeneron's common stock declined from a closing market price of $731.77 per share on April 28, 2026, to $686.36 per share on April 29, 2026, a decline of about 6.2% in the span of just a single day. Then, after-market on May 15, 2026, Regeneron announced that the "Phase 3 Trial of Fianlimab . . . did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS)." On this news, the price of Regeneron's common stock declined from $698.25 per share on May 15, 2026, to $629.68 per share on May 18, 2026, a decline of about 9.8% in the span of one day.

What can shareholders do now? You may be eligible to participate in the class action against Regeneron Therapeutics, Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by September 14, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, Robbins LLP has helped restore more than $1 billion in value to shareholders, secured some of the largest recoveries in shareholder derivative litigation history, and achieved governance reforms at over 400 Fortune 1000 companies.

"Behind everything we do is the belief that companies should be governed responsibly, fiduciaries should be held accountable, and shareholders deserve transparency and fairness," said Brian J. Robbins, Founding Partner of Robbins LLP.

To be notified if a class action against Regeneron Therapeutics, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Facebook
LinkedIn 

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306109

Source: Robbins LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Regeneron's clinical-trial risk disclosures are under scrutiny after allegations that the Company minimized Phase III Fianlimab-Libtayo statistical and protocol risks, including potential impact of FDA Otptimus-related amendments on progression-free survival analysis.

, /PRNewswire/ -- SueWallSt alerts investors in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) that a securities class action has been filed on behalf of shareholders who purchased REGN securities between August 1, 2025 and May 15, 2026. Submit your information now.

REGN shares allegedly declined $102.09 per share, or 13.95%, from the Class Period high of $731.77 on April 28, 2026 to $629.68 after disclosures concerning the Phase III Fianlimab-Libtayo Study. IMPORTANT DATE: September 14, 2026 is the deadline for investors seeking appointment as lead plaintiff.

Regulatory Compliance Risk Allegedly Became Investor Loss

The complaint challenges whether Regeneron adequately disclosed the clinical, statistical, and regulatory risks surrounding its Phase III Fianlimab-Libtayo Study. The case alleges that public statements minimized the risk that slowing event accrual reflected flaws in preliminary statistical assumptions, rather than durable efficacy in the active treatment arms.

As alleged, Regeneron's study design also had to account for FDA Optimus requirements concerning dose contribution. The lawsuit contends that the Company's statements did not sufficiently disclose that the active treatment arm was allegedly failing to show meaningful differentiation over standard therapies.

Disclosure Gaps Alleged in the Phase III Study

The action claims investors were not adequately informed that:

The prolonged slowdown in progression-free survival event accrual allegedly increased the risk of clinical failure. The study's statistical assumptions and design left it more vulnerable to missing its primary endpoint. The active treatment arm allegedly lacked meaningful clinical differentiation over pembrolizumab and other standard therapies. A protocol amendment expanded the PFS analysis population to include all patients with at least 6 months of follow-up. The study ultimately did not reach statistical significance for its primary endpoint of improved PFS. Alleged SEC Disclosure Adequacy Issues

The complaint alleges that Regeneron's public disclosures mischaracterized the actual risk of failure facing the study and minimized risks to the study's odds of achieving its primary endpoint and overall statistical validity. On April 29, 2026, Regeneron disclosed that the protocol had been changed to expand the eligible patient group for PFS analysis.

On May 15, 2026, after market close, Regeneron announced that the Phase 3 Trial of Fianlimab did not reach statistical significance for the primary endpoint of improvement in PFS. The lawsuit alleges these disclosures corrected earlier alleged misstatements and caused investors to suffer losses.

"Generic risk factor language cannot substitute for disclosing specific, known problems that are already affecting a company's operations. Here, investors should review whether the alleged protocol, statistical, and FDA Optimus-related protocol amendment risks were adequately disclosed before REGN shares declined." -- Joseph E. Levi, Esq.

Find out if you might qualify to recover losses

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the REGN Lawsuit

Q: What is the REGN class action lawsuit about? A: A securities class action has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) alleging materially false and misleading statements between August 1, 2025 and May 15, 2026. Shares fell approximately 13.95% after the Company disclosed a protocol amendment and later announced that the Phase 3 Fianlimab trial did not reach statistical significance for the primary endpoint of improvement in progression-free survival. Investors who purchased shares during the Class Period and suffered losses may be eligible to seek compensation.

Q: What specific misstatements does the REGN lawsuit allege? A: The complaint alleges Regeneron made materially false or misleading statements regarding the Phase III Fianlimab-Libtayo Study, including statements that allegedly characterized slowing event accrual as a potentially favorable sign while minimizing statistical validity and clinical-failure risks. When the protocol amendment and failed primary endpoint were disclosed, the stock price declined sharply.

Q: What court was the REGN class action filed in? A: The case was filed in the United States District Court for the Southern District of New York and is governed by the Private Securities Litigation Reform Act of 1995.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What documents do I need to submit my information? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my REGN shares, can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. If there is a settlement or recovery, eligible class members generally submit a claim form to seek their portion.

Q: What does it cost me to participate? A: There is no upfront cost to contact the firm. Securities class actions are generally handled on a pure contingency basis. No upfront fees, no retainer, and no out-of-pocket costs. Any attorneys' fees and expenses awarded to class counsel are subject to court approval.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (888) SueWallSt

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE SueWallSt.com

Key Takeaways TSMC lifted its 2026 revenue growth outlook above 40% after strong second-quarter results and AI demand.TSM expects N2 technology and broad customer demand to support continued third-quarter momentum.TSMC sees Agentic AI boosting CPU silicon demand while staying positioned across multiple CPU architectures. Taiwan Semiconductor Manufacturing Company (TSM - Free Report) , or TSMC, reported second-quarter 2026 revenues of $40.2 billion, up 33.7% from a year ago, driven by continued strong demand for leading-edge process technologies. The company expects that momentum to continue in the third quarter, helped by the rapid ramp-up of its 2-nanometer (N2) technology. Due to robust technology differentiation and the broad customer base, management also raised its full-year revenue growth forecast to slightly above 40% year over year in U.S. dollar terms, up from the previous projection of above 30%.

At the same time. TSMC acknowledged challenges in the consumer and price-sensitive end markets. Rising component prices and macroeconomic uncertainties continue to weigh on those markets, prompting the company to take a prudent approach to business planning while focusing on the fundamentals needed to strengthen its competitive position.

AI-related demand remains exceptionally strong. The AI megatrend continues to fuel the need for greater computation, supporting the robust demand for leading-edge silicon. TSMC’s customers, primarily cloud service providers, continue to signal a strong and positive outlook, underpinning confidence in the long-term AI opportunity. 

The company expects to benefit from the rise of Agentic AI, which is increasing the role of CPUs in AI data centers and driving additional silicon demand alongside AI accelerators. TSMC believes it is well-positioned, regardless of whether customers adopt x86, Arm-based or RISC-V architectures, and is working closely with CPU customers to provide the advanced technologies and capacity needed to capture the market opportunities.

TSM’s Peer UpdatesMicron Technology (MU - Free Report) is gaining from AI-led data center demand, tight industry supply and a richer mix of high-value memory and storage products. The company’s total revenues for the third quarter of fiscal 2026 came in at $41.46 billion, a remarkable increase from last year’s $9.30 billion, mainly due to higher sales of both Dynamic Random Access Memory (“DRAM”) and NAND products. For the fiscal fourth quarter, Micron has guided for revenues between $49 billion and $51 billion across both GAAP and Non-GAAP measures.

Intel (INTC - Free Report) is set to report its second-quarter 2026 results on July 23, following the market close. The company recently expanded its long-standing relationship with Fortinet by announcing a strategic collaboration to develop Fortinet Security Processor 6 (SP6). Fortinet’s proprietary, purpose-built security processor expertise will be combined with Intel’s advanced design, packaging and manufacturing capabilities to accelerate and strengthen SP6 development.The companies will also explore opportunities to expand their collaboration across semiconductor technology, manufacturing and the infrastructure that supports future cybersecurity innovation.

The Zacks Rundown for TSM StockYear to date, Taiwan Semiconductor shares have rallied 39.2%, slightly trailing the Zacks Semiconductor - Circuit Foundry industry’s 39.7% growth.

Image Source: Zacks Investment Research

In terms of valuation, TSM trades at a forward, 12-month Price/Sales (P/S) of 11.50X compared with its 10.98X median and the industry average of 11.46X.

Image Source: Zacks Investment Research

As shown below, earnings estimates for TSM have moved significantly higher following the July 16 earnings release.

Image Source: Zacks Investment Research

Taiwan Semiconductor sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Key Takeaways TMO posted Q2 adjusted EPS of $6.03 and revenues of $11.99 billion, both above estimates.Thermo Fisher delivered 5% organic revenue growth with stronger customer activity across end markets.TMO expanded adjusted operating margin to 22.8% as profitability improved across all four segments. Thermo Fisher Scientific (TMO - Free Report) delivered second-quarter 2026 adjusted earnings of $6.03 per share, up 13% year over year. The figure beat the Zacks Consensus Estimate by 5.6%.

Revenues rose 10% to $11.99 billion and surpassed the consensus mark by 2.67%. Results were supported by 5% organic revenue growth, while customer activity strengthened across the company’s end markets.

Following the earnings announcement, TMO stock rose 4.4% in pre-market trading today.

TMO's Segmental Growth BroadensLife Sciences Solutions revenues increased 12.6% year over year to $2.82 billion. Segment income rose to $1.04 billion from $919 million, while the segment income margin expanded 20 basis points to 37%.

Laboratory Products and Biopharma Services remained the largest business, with revenues climbing 11.6% to $6.69 billion. Segment income increased to $936 million from $825 million, and margin improved to 14% from 13.8%. The segment accounted for 55.8% of consolidated revenues before eliminations.

Analytical Instruments revenues advanced 6.9% to $1.85 billion. Segment income jumped to $424 million from $325 million, driving margin expansion to 23% from 18.8%. The improvement made this segment the strongest margin gainer in the quarter.

Specialty Diagnostics revenues grew 6.3% to $1.21 billion. Segment income reached $334 million compared with $306 million a year earlier, while margin increased to 27.7% from 27%. Together, the two smaller segments added growth without diluting overall operating profitability.

TMO Expands Operating LeverageAdjusted operating income increased 15% year over year to $2.74 billion. The adjusted operating margin widened 90 basis points (bps) to 22.8%, reflecting stronger profitability across all four business segments.

On a GAAP basis, operating income rose 14% to $2.09 billion, while the operating margin improved 50 bps year over year. The cost of revenues was $7.05 billion, selling, general and administrative expenses were $1.91 billion, and research and development spending totaled $364 million.

Thermo Fisher’s Cash Deployment Reflects Strategic MovesThermo Fisher ended the second quarter with cash and cash equivalents of $4.06 billion compared with $3.25 billion at the end of the first quarter.

Cumulative net cash provided by operating activities came to $3.32 billion, compared with $2.12 billion in the year-ago period.

The company repurchased $1 billion of stock during the quarter and announced the divestiture of its microbiology business. For the first six months of 2026, acquisitions net of cash acquired totaled $8.87 billion, share repurchases reached $4 billion, and dividends paid amounted to $337 million.

Thermo Fisher Deepens Customer PartnershipsThermo Fisher opened its flagship U.S. Bioprocess Design Center in Plainville, MA. The site expands its network of collaborative innovation hubs intended to help pharma and biotech customers accelerate drug development and optimize manufacturing.

The company also announced a collaboration with Precision Health Research, Singapore, to support the PRECISE-SG100K population health study. The project will use Thermo Fisher's integrated proteomics capabilities, including Olink technology and the Orbitrap Astral mass spectrometry system.

Our TakeThermo Fisher ended the second quarter with both earnings and revenues beating respective estimates. Performance reflected the strength of the company’s proven growth strategy, strong execution and the power of the PPI Business System. Expansion of the adjusted operating margin in the quarter is also very promising.

During the quarter, Thermo Fisher launched a range of high-impact, innovative new products, including the next-generation Orbitrap mass spectrometry platforms with AI-driven analytics. It also introduced the Applied Biosystems PowerFlex Thermal Cycler to improve workflow flexibility, speed and reproducibility in molecular biology laboratories.

TMO’s Zacks Rank and Key PicksThermo Fisher currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are Intuitive Surgical (ISRG - Free Report) , Danaher (DHR - Free Report) and Elevance Health (ELV - Free Report) .

Intuitive Surgical, carrying a Zacks Rank #2 (Buy), reported second-quarter 2026 adjusted EPS of $2.80, which surpassed the Zacks Consensus Estimate by 12.9%. Revenues of $2.89 billion beat the Zacks Consensus Estimate by 3.1%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

ISRG has an earnings yield of 3.1% compared to the industry’s negative 3% yield. The company beat earnings estimates in each of the trailing four quarters, the average surprise being 16.53%.

Danaher, carrying a Zacks Rank #2 at present, posted second-quarter 2026 adjusted EPS of $1.94, exceeding the Zacks Consensus Estimate by 5.44%. Revenues of $6.27 billion topped the Zacks Consensus Estimate by 2.88%.

DHR has an earnings yield of 4.7% compared to the industry’s 4.1% yield. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 5.65%.

Elevance Health, carrying a Zacks Rank #2 at present, posted second-quarter 2026 adjusted EPS of $7.45, exceeding the Zacks Consensus Estimate by 20.6%. Revenues of $49.8 billion outperformed the consensus mark by 0.8%.

ELV has an earnings yield of 6.9% compared to the industry’s 4.1% yield. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 5.65%.

Key Takeaways TXN highlighted broad demand recovery as industrial, automotive and data center markets drove growth.TXN's data center sales doubled year over year, while automotive demand improved with EV and hybrid strength.Texas Instruments is expanding capacity, citing clean room space and investments to support future demand. Texas Instruments Incorporated (TXN - Free Report) emphasized a broad-based demand recovery during its second-quarter fiscal 2026 earnings call, with management highlighting strength across the industrial, data center and automotive markets as key drivers. Revenues exceeded the Zacks Consensus Estimate, while executives focused more on improving demand trends and capacity readiness than on the quarter’s financial results.

Management highlighted expanding opportunities from inventory normalization, stronger customer demand and long-term investments in manufacturing capacity. The discussion also centered on pricing actions, data center growth and the company’s ability to support customers through the current cycle.

TXN Demand Broadens Across Industrial and Automotive MarketsCEO Haviv Ilan said second-quarter revenues reached $5.46 billion, up 23% year over year, with Analog revenues increasing 26% and Embedded Processing revenues rising 16%. Industrial, automotive and data center markets were the primary contributors to growth.

Ilan noted that industrial revenues increased around 30% year over year, automotive revenues grew in the mid-teens and data center revenues doubled from the prior-year period. He added that demand strength expanded beyond the earlier industrial and data center trends.

The company reported earnings per share (EPS) of $2.14, exceeding the Zacks Consensus Estimate of $1.91. Revenues of $5.46 billion also surpassed the Zacks Consensus Estimate of $5.22 billion.

Texas Instruments Sees Strength Across End Markets in Q2Texas Instruments said automotive demand improved during the second quarter of fiscal 2026, with Ilan attributing the improvement to stronger electric vehicle and hybrid demand, particularly in China, along with low customer inventory levels.

Management also discussed data center momentum, where sales doubled year over year. Ilan said higher-voltage architectures and increased power conversion needs could expand opportunities for Analog and Embedded products.

Personal electronics remained comparatively soft, as customer shortages continued to affect the market. Management still expects the segment to contribute to broader third-quarter growth.

Texas Instruments' Capacity Strategy Supports Long-Term GrowthTXN emphasized that its prior investments in inventory and manufacturing capacity are helping it respond to demand. Ilan said the company’s available clean room space positions it to support growth without the constraints experienced in previous cycles.

The company increased factory loadings from the first to the second quarter and said third-quarter decisions will depend on demand conditions. Management identified the Richardson, Sherman and Lehi facilities as key parts of its expansion strategy.

Capital spending remained focused on long-term capacity needs. CFO Rafael Lizardi said 2026 capital expenditures are expected to remain within the $2-$3 billion range, with spending decisions tied to future demand scenarios.

Texas Instruments Pricing Actions Support Future Growth PathTexas Instruments said pricing was stable during the first half of the year, which management described as better than its typical annual pricing trend. Ilan said the company has started implementing price increases for customers.

Management expects pricing benefits to appear gradually, beginning in the third quarter of fiscal 2026 and extending into future periods, depending on customer discussions and annual pricing cycles.

Analysts also questioned whether the strength in the industrial market was driven by pricing or product value. Management said the second-quarter improvement was primarily driven by secular content growth, inventory normalization and new system demand.

TXN Outlook Reflects Broad-Based Growth Across Key MarketsTXN guided third-quarter revenues to a range of $5.65-$6.15 billion and EPS to $2.23-$2.57. Management expects strength across the industrial, data center, automotive and personal electronics markets.

A JPMorgan analyst asked about automotive momentum and pricing actions. Ilan said demand improved during the second quarter and reflected broader customer needs rather than a single market factor.

A Goldman Sachs analyst asked about inventory and factory utilization. Management said inventory declined sequentially and that available capacity gives TXN the flexibility to respond as demand evolves.

Texas Instruments Closing ViewTexas Instruments maintained that its long-term value creation remains tied to manufacturing strength, technology investments, product breadth and disciplined capital allocation. Management reiterated that free cash flow per share growth remains its key performance objective.

The company reported trailing 12-month free cash flow of $6.5 billion and returned $5.8 billion to shareholders during the same period. Management continued to emphasize balancing capacity investment with shareholder returns.

Texas Instruments Zacks RankTXN carries a Zacks Rank #2 (Buy). The Zacks Rank focuses on earnings estimate revisions and is designed to help identify stocks with stronger potential performance over the next one to three months. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The stock has a Value Score of D, Growth Score of B, Momentum Score of B and VGM Score of C. Zacks Style Scores evaluate value, growth and momentum characteristics, with higher scores indicating stronger attributes within each style category.
The Zacks Rank can change as analysts update earnings estimates following new company information, including developments after the latest quarterly results.

Vertical Aerospace: Pre-Flight Checks Point to a BreakoutHoneywell International NASDAQ: HON reported stronger-than-expected second-quarter 2026 results for its newly defined Honeywell Technologies business and raised its full-year outlook, citing broad order strength, margin expansion and momentum across its automation-focused portfolio.

Chairman and Chief Executive Officer Vimal Kapur said the quarter marked “an important milestone” as the company began operating as a pure-play automation company following the June 29 spin-off of Honeywell Aerospace. Senior Vice President of Investor Relations Mark Macaluso noted that the results and guidance discussed on the call exclude Honeywell Aerospace, remove pension income and Quantinuum from adjusted results, and reflect the impact of a one-for-two reverse stock split on adjusted earnings per share.

Get HON alerts:

Brady Corp Wires Up a Massive AI-Powered BreakoutKapur said Honeywell Technologies delivered 4% organic sales growth in the quarter, driven by continued strength in Building Automation and better-than-expected performance in Process Automation and Technology, or PA&T, and Industrial Automation. Organic orders rose 16%, while ending backlog increased 9%.

“Our results this quarter have demonstrated the strength of the new Honeywell Technologies portfolio,” Kapur said.

Second-Quarter Results Top Expectations Boarding Passes Now Being Issued for the Ultimate eVTOL ArbitrageChief Financial Officer Mike Stepniak said total sales grew 4% organically in the second quarter. Building Automation led the company’s growth with a 9% organic sales increase, supported by double-digit growth in products and continued strength in solutions. Stepniak said the segment saw double-digit growth in both fire and services, with regional strength led by Asia Pacific, the Middle East and the Americas.

Industrial Automation sales rose 4%, exceeding expectations, with strength in solutions and continued momentum in sensing and industrial measurement. Excluding planned divestitures, the core Industrial Automation business grew 2% organically.

Process Automation and Technology sales declined 1% organically, but Stepniak said the result was materially ahead of Honeywell’s prior outlook. Projects grew 5%, driven by gas, LNG and petrochemicals, while aftermarket sales declined 6% due largely to a tough comparison with a large catalyst shipment in the second quarter of 2025.

Segment profit increased 9%, and segment margin expanded 100 basis points to 19%. Building Automation margin rose 90 basis points to 27.1%, while Industrial Automation margin increased 90 basis points to 17.2%. PA&T margin contracted 180 basis points to 22.1% because of unfavorable mix from lower catalyst volumes, though Stepniak said that was also ahead of the company’s original margin outlook.

Adjusted earnings per share were $1.95, up 10% from the prior year. Stepniak said the increase was primarily driven by higher segment profit, lower net interest expense tied to debt paydown and a lower share count, partially offset by higher repositioning costs and a $0.16 headwind from a higher adjusted effective tax rate.

Honeywell Raises 2026 Guidance Honeywell raised its full-year organic sales growth outlook to 3% to 4%, up from previous guidance of 2% to 3%. The company now expects second-half organic growth of 4% to 6%, compared with its prior outlook of 3% to 5%.

Stepniak said Building Automation is expected to deliver mid-single-digit-plus organic growth, supported by strong orders in focus verticals including healthcare, hospitality and data centers. PA&T is expected to accelerate to high-single-digit growth in the second half as global energy projects resume, backlog conversion improves and catalyst shipment volumes rise significantly. Industrial Automation is also expected to grow in the second half, supported by short-cycle demand for industrial measurement and sensing, continued growth in Europe and China, and strengthening demand in the Americas.

The company also raised its full-year segment margin expansion outlook to 250 to 290 basis points, up 25 basis points at the midpoint. Stepniak said the improvement reflects second-quarter outperformance, progress on stranded cost elimination and accretion related to the accelerated timing of divestitures.

Honeywell now expects full-year adjusted EPS of $8.20 at the midpoint, up from $8.10 previously and approximately 27% higher than the prior year. The company maintained its expectation for roughly $2 billion of free cash flow in 2026, with most of that expected in the second half and an approximately 95% conversion rate.

Portfolio Transformation Advances Kapur said Honeywell completed the separation of Honeywell Aerospace and supported Quantinuum’s successful initial public offering in June. Honeywell retains a 47% ownership stake in Quantinuum, and Kapur said the company expects to provide more color on its plans for that stake by early next year.

The company also closed its acquisition of Johnson Matthey’s Catalyst Technologies business on July 17. Kapur said the business will become part of the PA&T segment and will expand Honeywell UOP’s capabilities across refining, petrochemicals and renewable fuels. He said the acquisition adds a differentiated technology portfolio and expands Honeywell’s installed base.

In response to an analyst question, Kapur said Honeywell acquired the business for commercial synergies, though the company is not counting those in the early stages. Stepniak added that Honeywell believes it acquired the business “at the bottom” and said second-half catalyst activity looks stronger, including within Honeywell’s own catalyst business.

Honeywell also expects to close divestitures of the Productivity Solutions and Services and Warehouse and Workflow Solutions businesses by early August, about two months ahead of its initial planning assumption. Kapur said the accelerated timing reduced 2026 revenue expectations by about $400 million but should sharpen focus and simplify the Industrial Automation portfolio.

Orders Strength and End-Market Trends Kapur highlighted broad-based order momentum across the company. PA&T orders rose 24% organically, with process technology orders up roughly 50%, producing a book-to-bill ratio above 1.2 for the segment. Total company book-to-bill was 1.1.

Building Automation orders were supported by high-growth verticals, where Kapur said orders rose more than 50% and organic sales grew 30%. The fire business also posted approximately 30% orders growth. In Industrial Automation, orders in the remaining core business after divestitures rose 11%, or 7% sequentially, while sensing and industrial measurement orders increased more than 20%.

On the Middle East, Kapur said Honeywell is assuming current conditions persist without a significant escalation or further supply chain disruption. He said the company experienced some revenue loss in the first and second quarters and modest collection issues in pockets, but no major disputes. Stepniak said most of the collection issues occurred in March and April and have started to normalize.

Asked about data centers, Kapur said Honeywell sees opportunities beyond fire, security and building management systems. He cited growth outside the U.S., on-site power generation that could involve Process Automation, and longer-term opportunities in liquid cooling sensors.

Long-Term Targets Reaffirmed Kapur said Honeywell’s strategy is centered on growing its installed base and monetizing it through software, services and outcome-based solutions. He said the company is increasing exposure to higher-growth verticals such as data centers, LNG, grid infrastructure and life sciences.

The company reiterated long-term goals discussed at its June Investor Day, including adjusted EPS of approximately $12, more than 10% annual adjusted EPS growth and free cash flow conversion above 90%. Kapur said margin expansion is expected to come from stranded cost removal, portfolio actions, an aerospace trademark agreement, price, mix, new product introductions and productivity.

“We are pleased with Honeywell Technologies’ second quarter results, which enabled us to increase our 2026 outlooks across all key metrics,” Kapur said. “Today is only the beginning of that journey.”

About Honeywell International (NASDAQ:HON)Honeywell International Inc is a diversified, publicly traded multinational conglomerate NASDAQ: HON that designs and manufactures a wide range of commercial and consumer products, engineering services and aerospace systems. The company operates through major business platforms that historically include Aerospace; Building Technologies; Performance Materials and Technologies; and Safety and Productivity Solutions. Its portfolio spans avionics and propulsion systems, building controls and HVAC equipment, process technologies and advanced materials, industrial automation software, and personal protective equipment and scanning solutions.

Honeywell's aerospace business supplies aircraft manufacturers and operators with engines and auxiliary power units, avionics, flight safety systems and aftermarket services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Honeywell International Right Now?Before you consider Honeywell International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Honeywell International wasn't on the list.

While Honeywell International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Union Pacific (UNP - Free Report) came out with quarterly earnings of $3.41 per share, beating the Zacks Consensus Estimate of $3.2 per share. This compares to earnings of $3.03 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +6.56%. A quarter ago, it was expected that this railroad would post earnings of $2.85 per share when it actually produced earnings of $2.93, delivering a surprise of +2.81%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Union Pacific, which belongs to the Zacks Transportation - Rail industry, posted revenues of $6.86 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.18%. This compares to year-ago revenues of $6.15 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Union Pacific shares have added about 26.5% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for Union Pacific?While Union Pacific has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Union Pacific was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $3.32 on $6.73 billion in revenues for the coming quarter and $12.62 on $26.04 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Transportation - Rail is currently in the bottom 24% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Canadian National (CNI - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on July 24.

This railroad is expected to post quarterly earnings of $1.39 per share in its upcoming report, which represents a year-over-year change of +3%. The consensus EPS estimate for the quarter has been revised 1.7% lower over the last 30 days to the current level.

Canadian National's revenues are expected to be $3.26 billion, up 5.5% from the year-ago quarter.

Key Takeaways RTX topped Q2 EPS and revenue estimates as commercial aftermarket and defense demand fueled growth.RTX secured $43B in new awards, lifting backlog 22% to $289B with strong commercial and defense orders.RTX raised 2026 sales, organic growth, adjusted EPS and free cash flow guidance after strong Q2 results. RTX Corporation’s (RTX - Free Report) second-quarter 2026 adjusted earnings per share (EPS) of $1.89 beat the Zacks Consensus Estimate of $1.66 by 13.9%. The bottom line improved 21.1% from the year-ago quarter’s level of $1.56.

RTX’s Total RevenuesRevenues rose 14.5% year over year to $24.71 billion and beat the consensus mark of $22.83 billion by 8.2%. Growth was supported by higher commercial aftermarket and defense demand. Backlog climbed 22% to $289 billion.

RTX Corporation Price, Consensus and EPS SurpriseRTX Benefits From Broad-Based Organic GrowthOrganic sales advanced 16% in the quarter. Commercial aftermarket revenues increased 18%, while defense sales grew 16%, excluding acquisitions, divestitures and foreign-currency effects. Commercial original equipment sales were up 9%.

The company secured $43 billion of new awards during the quarter, including nearly $20 billion at Raytheon. The total backlog comprised $170 billion of commercial orders and $119 billion of defense orders, providing strong visibility into future production requirements.

RTX’s Operational PerformanceTotal costs and expenses increased 12.8% year over year to $21.96 billion. Cost of sales rose to $19.58 billion from $17.21 billion, while selling, general and administrative expenses increased to $1.66 billion from $1.57 billion.

Adjusted segment operating profit advanced 18%, with consolidated adjusted segment margin expanding 40 basis points to 12.4%. Reported operating profit rose to $2.81 billion from $2.15 billion, while the reported operating margin improved to 11.4% from 9.9%.

RTX’s Segmental PerformanceCollins Aerospace generated sales of $8.21 billion, up 8% year over year and 13% organically. Commercial original equipment sales increased 26%, commercial aftermarket revenues rose 10%, and defense sales improved 7%.

Pratt & Whitney’s sales rose 16% to $8.89 billion, with organic growth of 17%. Commercial aftermarket sales jumped 25%, and military revenues increased 23%. Commercial original equipment sales declined 8% due to large commercial engine mix.

Raytheon recorded sales of $8.27 billion, up 18% year over year. The growth reflected higher volumes across land and air defense systems, naval programs, and air and space defense systems, including Patriot, Standard Missile and AMRAAM programs.

RTX’s Financial UpdateRTX had cash and cash equivalents of $8.31 billion as of June 30, 2026, compared with $7.44 billion as of Dec. 31, 2025.

The long-term debt totaled $31.86 billion as of June 30, 2026, compared with $34.29 billion as of Dec. 31, 2025.

Operating cash flow totaled $3.55 billion compared with $458 million in the prior-year quarter. Capital expenditures were $669 million, resulting in free cash flow of $2.88 billion versus negative $72 million a year earlier.

RTX Raises Its 2026 Financial OutlookRTX raised its 2026 adjusted sales guidance to $95-$96 billion from $92.5-$93.5 billion. The company now expects organic sales growth of 8-9% compared with its prior projection of 5-6%.

Adjusted earnings are projected to be between $7.10 and $7.25 per share, up from $6.70-$6.90. Free cash flow is expected to be in the range of $8.50-$8.75 billion compared with the previous forecast of $8.25-$8.75 billion.

RTX’s Zacks RankThe company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Upcoming Defense ReleasesTextron (TXT - Free Report) is slated to report second-quarter results on July 28, before market open. The Zacks Consensus Estimate for earnings is pegged at $1.52 per share, indicating a year-over-year decline of 1.9%.

TXT’s long-term (three to five years) earnings growth rate is 10.14%. The Zacks Consensus Estimate for second-quarter sales is pinned at $3.82 billion, indicating year-over-year growth of 2.8%.

General Dynamics (GD - Free Report) is slated to report second-quarter results on July 29, before market open. The Zacks Consensus Estimate for earnings is pegged at $3.95 per share, which indicates a year-over-year increase of 5.6%.

GD’s long-term earnings growth rate is 9.97%. The Zacks Consensus Estimate for second-quarter sales is pegged at $13.49 billion, which indicates a year-over-year increase of 3.4%.

L3Harris Technologies (LHX - Free Report) is slated to report second-quarter results on July 29, after market close. The Zacks Consensus Estimate for earnings is pegged at $2.80 per share.

LHX’s long-term earnings growth rate is 17.11%. The Zacks Consensus Estimate for second-quarter sales is pinned at $5.79 billion, indicating year-over-year growth of 6.8%.

For the quarter ended June 2026, RTX (RTX - Free Report) reported revenue of $24.71 billion, up 14.5% over the same period last year. EPS came in at $1.89, compared to $1.56 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $22.83 billion, representing a surprise of +8.21%. The company delivered an EPS surprise of +13.86%, with the consensus EPS estimate being $1.66.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how RTX performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Adjusted Net Sales- Collins Aerospace: $8.21 billion compared to the $7.83 billion average estimate based on two analysts. The reported number represents a change of +7.7% year over year.Net Sales- Raytheon: $8.27 billion compared to the $7.54 billion average estimate based on two analysts. The reported number represents a change of +18.1% year over year.Adjusted Net Sales- Pratt & Whitney: $8.89 billion compared to the $8.16 billion average estimate based on two analysts. The reported number represents a change of +16.5% year over year.Adjusted Net Sales- Eliminations & Other: $-660 million versus the two-analyst average estimate of $-704.36 million. The reported number represents a year-over-year change of -1.9%.Net Sales- Eliminations and other: $-660 million compared to the $-704.36 million average estimate based on two analysts. The reported number represents a change of -1.9% year over year.Operating Profit- Collins Aerospace- Adjusted: $1.37 billion versus $1.32 billion estimated by two analysts on average.Operating Profit- Raytheon- Adjusted: $1.04 billion versus the two-analyst average estimate of $895.79 million.Operating Profit- Pratt & Whitney- Adjusted: $740 million compared to the $700.71 million average estimate based on two analysts.Operating Profit- Corporate expenses and other unallocated items- Adjusted: $7 million versus the two-analyst average estimate of $-64.75 million.Operating Profit- Eliminations and Other- Adjusted: $28 million versus $-21.25 million estimated by two analysts on average.View all Key Company Metrics for RTX here>>>

Shares of RTX have returned +5.3% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Key Takeaways ServiceNow beat Q2 earnings and revenue estimates and raised its fiscal 2026 subscription revenue outlook.NOW's AI business topped $1B in ACV as enterprise adoption and agentic AI deployments accelerated.ServiceNow reported 98% renewal rates, rising cRPO, and strong large-customer and AI product momentum. ServiceNow (NOW - Free Report) reported impressive second-quarter fiscal 2026 results, surpassing Wall Street expectations on both the top and bottom lines as accelerating adoption of its AI platform, robust enterprise demand, and continued execution across its workflow portfolio fueled another quarter of strong growth.

The company reported non-GAAP earnings of 90 cents per share, which beat the Zacks Consensus Estimate of 86 cents by 4.7%. Revenues totaled $3.99 billion, exceeding the consensus estimate of $3.92 billion.

Subscription revenues, ServiceNow's largest business, climbed 24.5% year over year to $3.88 billion, while current remaining performance obligations (cRPO) rose 21% to $13.2 billion, reflecting continued customer demand and longer contract durations. Remaining performance obligations reached $29 billion, up 21% from the prior-year period.

Management highlighted that the company exceeded the high end of its guidance across every major top-line and profitability metric. Chairman and CEO Bill McDermott noted that ServiceNow AI surpassed $1 billion in annual contract value (ACV) during the quarter, while agentic AI deployments increased ninefold over the past nine months. He emphasized that enterprises increasingly view ServiceNow's AI Control Tower as the governance layer required to securely deploy AI across organizations.

President and CFO Gina Mastantuono said AI demand continued to outperform internal expectations, with net new AI ACV accelerating sequentially and customers increasingly adopting multiple AI products simultaneously. The company also reported a best-in-class renewal rate of 98%, ended the quarter with 658 customers generating more than $5 million in ACV, and recorded 123 transactions exceeding $1 million in net new ACV, representing nearly 40% year-over-year growth.

AI Platform Driving Enterprise ExpansionManagement devoted much of the earnings call to highlighting the growing strategic importance of the company's AI platform.

During the quarter, ServiceNow launched Otto, a unified AI experience integrating Now Assist, Moveworks, and AI Experience. The company also expanded AI Control Tower with enhanced governance, security, and observability capabilities while introducing new autonomous AI specialists across IT, CRM, employee services and security.

Executives stressed that enterprises are moving beyond AI experimentation toward measurable business outcomes. According to management, customers increasingly favor deterministic AI capable of completing work rather than simply providing recommendations.

The company also pointed to strong momentum across cybersecurity, where AI Control Tower, Armis, and Veza are expanding ServiceNow's security portfolio. McDermott described cybersecurity as one of the company's fastest-growing businesses and a significant long-term growth opportunity.

Beyond AI, ServiceNow strengthened partnerships with NVIDIA, Microsoft, AWS, Accenture, Experian, Lenovo, FedEx, and TeamViewer while outlining ambitious long-term financial targets during its Financial Analyst Day, including more than $30 billion in subscription revenues and a Rule of 60+ by 2030.

Guidance Raised Following Strong QuarterEncouraged by stronger-than-expected net new ACV generation, ServiceNow raised its full-year subscription revenue outlook.

For the third quarter of fiscal 2026, the company expects subscription revenues to be between $3.975 billion and $3.980 billion, representing approximately 20% constant currency growth, with cRPO growth of roughly 20%.

For fiscal 2026, ServiceNow now projects subscription revenues of $15.76 billion to $15.78 billion, implying approximately 21% constant currency growth. Management expects subscription gross margin of 81%, operating margin of 31.5%, and free cash flow margin of 35%.

Executives acknowledged that stronger U.S. federal demand accelerated some on-premise subscription revenues into the second quarter, but emphasized that underlying net new ACV strength, not timing alone, supported the higher full-year guidance.

Management CommentaryDuring the question-and-answer session, executives expressed confidence that AI adoption remains in its early stages.

Management highlighted that more than 40 customers are already deploying its Level 1 AI specialists, with some organizations automating 80-85% of service requests while reducing resolution times from days to approximately 20 minutes. The company also indicated that first-time buyers of ServiceNow's agentic AI products increased more than 45% year over year, reinforcing expectations that AI will account for 30% of ACV by 2030.

Executives further emphasized that ServiceNow's hybrid AI pricing model, combining licensing and usage-based elements, continues to resonate with enterprise customers while supporting pricing uplifts consistent with previously communicated targets.

Zacks Rank & Style ScoresServiceNow currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The stock has a Value Score of D, a Growth Score of B, a Momentum Score of A, and a VGM Score of B.

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Intuit Inc. ("Intuit" or the "Company") (NASDAQ: INTU) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-07086, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Intuit securities between August 22, 2025 and May 20, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are an investor who purchased or otherwise acquired Intuit securities during the Class Period, you have until September 8, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.  

[Click here for information about joining the class action]

Intuit provides financial management, payments and capital, compliance, and marketing products and services in the United States. The Company has four reportable business segments: (i) Global Business Solutions; (ii) Consumer; (iii) Credit Karma; and (iv) ProTax.  Intuit's Consumer segment provides do-it-yourself ("DIY") and assisted income tax preparation products and services under the "TurboTax" brand name, whereas its ProTax segment provides tax-preparation software products and electronic tax filing, payment, and related products and services.  The Company sells its products and services through direct sales channels, multichannel shop-and-buy experiences, mobile application stores, and partner and other channels.

At all relevant times, Defendants touted purportedly significant "momentum" across Intuit's various business segments, particularly with respect to its tax-related business.  Defendants attributed this purported "momentum" to, inter alia, Intuit's purportedly significant competitive advantages, including integration of artificial intelligence ("AI") in its business and operations.

For example, in August 2025, Defendants provided financial guidance for Intuit's fiscal full year ("FY") of 2026, ended July 31, 2026, including 8% revenue growth in its TurboTax business, citing "outstanding execution across our platform" and "breakthrough adoption in assisted tax" as a result of the aforementioned purported competitive advantages.

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) they had overstated Intuit's competitive advantages and growth, as well as the overall strength and sustainability of its business model and operations; (ii) in reality, Intuit was losing significant business in its tax-related business, particularly in its TurboTax business, as a result of, inter alia, increasing competitive and pricing pressures; (iii) accordingly, Intuit's previously issued FY 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times.

The truth began to emerge on May 20, 2026, when, during pre-market hours, Reuters published an article entitled "Intuit to cut 17% of global jobs to streamline operations, memo shows".  Citing an internal Company memorandum and email from Defendant Sasan K. Goodarzi ("Goodarzi"), Intuit's Chairman and Chief Executive Officer, to staff earlier in the day, the article reported that "Intuit . . . is laying off about 17% of its workforce, or about 3,000 employees worldwide, to streamline operations and sharpen focus on its key bets including its AI efforts[.]"  The article further revealed that Intuit "is also winding down its Reno and Woodland Hills offices as ⁠part of a strategic restructuring to consolidate teams in key hubs, according to the memo."

On this news, Intuit's stock price fell $15.78 per share, or 3.95%, to close at $383.93 per share on May 20, 2026.

The same day, during post-market hours, Intuit issued a press release announcing its fiscal third quarter ("Q3") 2026 results.  Therein, Defendants reported weak Q3 2026 tax season revenue, including, inter alia, TurboTax revenue that grew by only 7% year-over-year, versus consensus estimates of at least 8% revenue growth.  During the accompanying earnings call held the same day, also during post-market hours, Defendant Sandeep S. Aujla, Intuit's Executive Vice President and Chief Financial Officer, acknowledged that, with respect to TurboTax, "we did not have the overall tax season we expected[.]"  On the same call, Defendant Goodarzi likewise stated that he was "dissatisfied with our performance", noting "[w]e faced pressure among the most price-sensitive DIY filers earning less than $50,000 a year", and that "[w]e lost on price."  Defendant Goodarzi also revealed that TurboTax online paying units were expected to grow by only 2% as total Internal Revenue Service filers were expected to decline by approximately 30 basis points, representing the "most significant industry-wide contraction since the post-COVID tax season."  Accordingly, Defendant Goodarzi acknowledged that "we expect TurboTax to grow 7% for the full year"—down from Defendants' prior guidance of 8% growth—and that, "[t]o reaccelerate this part of our business," Defendants will need to "evolve our business model by delivering the right lineups and price points to meet simple filers' needs at the low end and lean into the power of our broader Consumer platform to monetize beyond tax."

Following these disclosures, Intuit's stock price fell $76.86 per share, or 20.02%, to close at $307.07 per share on May 21, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:

Danielle Peyton

Pomerantz LLP

[email protected]

646-581-9980 ext. 7980

SOURCE Pomerantz LLP

, /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Intuit Inc. (NASDAQ: INTU) securities between August 22, 2025 and May 20, 2026.  Intuit provides financial management, payments and capital, compliance, and marketing products and services in the U.S.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is the class period? August 22, 2025 – May 20, 2026

What are the allegations? 

Shareholders allege that Inuit Inc. misled investors regarding the Company's sustainability and growth.

According to the complaint, during the class period, defendants failed to disclose to investors that:

they had overstated Intuit's competitive advantages and growth, as well as the overall strength and sustainability of its business model and operations; in reality, Intuit was losing significant business in its tax-related business, particularly in its Turbo Tax business, because of, inter alia, increasing competitive and pricing pressures; and accordingly, Intuit's previously issued FY 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic. Plaintiff alleges that the truth began to emerge on May 20, 2026, when Reuters published an article entitled "Intuit to cut 17% of global jobs to streamline operations, memo shows". Citing an internal Company memorandum and email from defendant Sasan K. Goodarzi, Intuit's Chairman and Chief Executive Officer, to staff earlier in the day, the article reported that "Intuit . . . is laying off about 17% of its workforce, or about 3,000 employees worldwide, to streamline operations and sharpen focus on its key bets including its AI efforts[.]" The article further revealed that Intuit "is also winding down its Reno and Woodland Hills offices as ⁠part of a strategic restructuring to consolidate teams in key hubs, according to the memo." On this news, Intuit's stock price fell $15.78 per share, or 3.95%, to close at $383.93 per share on May 20, 2026.

The same day, during post-market hours, Intuit announced disappointing fiscal third quarter 2026 results. Following the news, Intuit's stock price fell $76.86 per share, or 20.02%, to close at $307.07 per share on May 21, 2026.

What Now: You may be eligible to participate in the class action against Intuit Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by September 8, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses. 

About Robbins LLP: A recognized leader in shareholder rights litigation, Robbins LLP has helped restore more than $1 billion in value to shareholders, secured some of the largest recoveries in shareholder derivative litigation history, and achieved governance reforms at over 400 Fortune 1000 companies. 

"Behind everything we do is the belief that companies should be governed responsibly, fiduciaries should be held accountable, and shareholders deserve transparency and fairness," said Brian J. Robbins, Founding Partner of Robbins LLP.

To be notified if a class action against Intuit Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising.  Past results do not guarantee a similar outcome.  

SOURCE Robbins LLP

New York, New York--(Newsfile Corp. - July 23, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Intuit Inc. (NASDAQ: INTU) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Intuit securities between August 22, 2025 and May 20, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/INTU.

Intuit Case Details

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that:

they had overstated Intuit's competitive advantages and growth, as well as the overall strength and sustainability of its business model and operations; in reality, Intuit was losing significant business in its tax-related business, particularly in its TurboTax business, as a result of, inter alia, increasing competitive and pricing pressures; accordingly, Intuit's previously issued FY 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic; and as a result, Defendants' public statements were materially false and misleading at all relevant times.What's Next for Intuit Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/INTU, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Intuit you have until September 8, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Intuit Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Intuit Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304944

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

U.S. stocks were lower, with the Dow Jones index dipping around 450 points on Thursday.

Lockheed Martin reported quarterly earnings of $7.94 per share which beat the analyst consensus estimate of $7.09 per share. The company reported quarterly sales of $20.063 billion which beat the analyst consensus estimate of $19.344 billion.

Lockheed Martin shares jumped 11.4% to $573.21 on Thursday.

Here are some other big stocks recording gains in today’s session.

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

© KuntalSaha / iStock Editorial via Getty Images

Defense primes are ripping higher Thursday morning even as the broader market sags. Lockheed Martin (NYSE:LMT | LMT Price Prediction) stock is up 10% to $567.71, while RTX (NYSE:RTX) shares are up 7% to $208.48. The S&P 500 is down 1.16%, making the divergence a standout story of today’s session.

The move follows beat-and-raise Q2 2026 results from both of these defense contractors, released before the open. Investors are treating the results as confirmation that global rearmament is still translating into record backlogs and rising cash flow.

Beat-and-Raise Quarters With Record Backlogs Lockheed Martin posted adjusted EPS of $7.94 on revenue of $20.1 billion, up 11% year over year, versus roughly $7.23 and $19.37 billion expected. The company booked $65 billion of new Q2 orders, including a multi-year $35 billion THAAD interceptor agreement with the Missile Defense Agency, taking backlog to a record $230 billion.

Management raised Lockheed Martin’s full-year 2026 guidance across the board, lifting EPS to $29.95 to $30.65, revenue to $79.75 billion to $81.75 billion, and free cash flow to $7 billion to $7.2 billion. Lockheed Martin CEO Jim Taiclet, in the company’s 8-K filing, cited a “higher trajectory for our business.” One nuance: the year-over-year profit swing benefits from easy comps, since the prior-year period absorbed about $1.6 billion in losses tied to a classified program and helicopter contracts.

Meanwhile, RTX’s report was even more striking on the top line. The company delivered adjusted EPS of $1.89 on revenue of $24.7 billion, up 16% organically, its fifth consecutive beat. The company’s backlog hit a record $289 billion ($170 billion commercial aerospace, $119 billion defense), with Q2 free cash flow of $2.9 billion.

Furthermore, RTX raised its full-year outlook to EPS of $7.10 to $7.25, revenue of $95 billion to $96 billion, and organic sales growth of 8% to 9% from 5% to 6%. CEO Chris Calio stated that “demand remains robust, and our backlog is up 22 percent year over year.” Patriot, Standard Missile, and AMRAAM volume drove the Raytheon segment, while Pratt & Whitney’s commercial aftermarket climbed 25%.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and RTX didn't make the cut. Grab the names FREE today.

Sector Strength Lifts Boeing and the Defense ETF The rally is spilling across aerospace and defense. Boeing (NYSE:BA) stock is unchanged at $209, which might not sound impressive but bear in mind that the stock market is down overall. Boeing didn’t report today, so the move reads as sympathy strength on broader aerospace sentiment rather than a company-specific catalyst.

The iShares U.S. Aerospace & Defense ETF (NYSEARCA:ITA) is also trading higher with the group, giving investors a diversified way to play the theme. The fund holds Lockheed Martin, RTX, and Boeing, with RTX among its top weights. Investors should note the ETF’s single-sector concentration in a handful of large-cap names, though it’s not leveraged.

The rally comes on top of a strong year. Lockheed Martin stock has climbed 37% over the past 12 months, and RTX shares are up 35%. Both have run hard, and while the bull case rests on sustained defense budgets, program execution, and orderly conversion of backlog into cash, government budget dependence and fixed-price program risk remain real overhangs.

What to Watch Lockheed Martin’s earnings call took place at 8:30 a.m. ET, and RTX’s kicked off at 7:30 a.m. ET, so any color on munitions capacity and F-35 delivery cadence should filter through analyst notes by midday. Investors can watch for whether LMT stock and RTX shares hold their morning gains into the close and whether sell-side price targets follow the raised guidance higher.

Position sizing should stay measured given how much these names have already appreciated. With backlogs at records and guidance raised across both companies, the setup favors the bulls, but the easy money on the initial earnings pop may already be priced in.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and RTX didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

The Computer and Technology group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Broadcom Inc. (AVGO - Free Report) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Computer and Technology peers, we might be able to answer that question.

Broadcom Inc. is a member of our Computer and Technology group, which includes 612 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Broadcom Inc. is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for AVGO's full-year earnings has moved 2.9% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Our latest available data shows that AVGO has returned about 14.7% since the start of the calendar year. Meanwhile, stocks in the Computer and Technology group have gained about 13.2% on average. This shows that Broadcom Inc. is outperforming its peers so far this year.

Another stock in the Computer and Technology sector, Lenovo Group Ltd. (LNVGY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 161.5%.

The consensus estimate for Lenovo Group Ltd.'s current year EPS has increased 59.7% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).

Looking more specifically, Broadcom Inc. belongs to the Electronics - Semiconductors industry, a group that includes 50 individual stocks and currently sits at #55 in the Zacks Industry Rank. On average, stocks in this group have gained 35.3% this year, meaning that AVGO is slightly underperforming its industry in terms of year-to-date returns.

In contrast, Lenovo Group Ltd. falls under the Computer - Micro Computers industry. Currently, this industry has 5 stocks and is ranked #19. Since the beginning of the year, the industry has moved +24.7%.

Going forward, investors interested in Computer and Technology stocks should continue to pay close attention to Broadcom Inc. and Lenovo Group Ltd. as they could maintain their solid performance.